Serum Proinflammatory Mediators at Different Periods of Therapy in Patients With Multiple Myeloma
Main Authors: | Irfan Kuku, Mehmet Refik Bayraktar, Emin Kaya, Mehmet Ali Erkurt, Nihayet Bayraktar, Kerim Cıkım, Ismet Aydogdu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2005-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/MI.2005.171 |
Similar Items
-
Nodular melanoma presenting with rapid progression and widespread metastases: a case report
by: Erkurt Mehmet, et al.
Published: (2009-02-01) -
Evaluation of Ferric and Ferrous Iron Therapies in Women with Iron Deficiency Anaemia
by: Ilhami Berber, et al.
Published: (2014-01-01) -
Experience of BK Virus in Allogenic and Autologous Bone Marrow Transplantation:
by: Ilhami BERBER, et al.
Published: (2014-08-01) -
Türkiye'nin doğusunda non-Hodgkin lenfoma hastalarının klinik ve patolojik özellikleri
by: Ali Dogan, et al.
Published: (2020-06-01) -
IL-21 and other serum proinflammatory cytokine levels in patients with multiple myeloma at diagnosis
by: O Mehtap, et al.
Published: (2014-01-01)